Zhang Rui-Cheng, Mu Ying-Feng, Dong Jing, Lin Xiao-Qian, Geng De-Qin
Rev Neurosci. 2017 Jan 1;28(1):59-64. doi: 10.1515/revneuro-2016-0013.
Pituitary adenoma apoplexy is a well-known clinical syndrome induced by insulin infusion, cardiac surgery, trauma, and hypothalamic releasing factors. Pituitary apoplexy can cause secondary cerebral infarct and internal carotid artery occlusion. With blockade of tumor perfusion, apoplexy triggers a sudden onset of headache, visual impairment, cranial nerve palsy, disturbances of consciousness, eyelid ptosis, and hemiparesis. However, pituitary adenoma cells with high metabolic demand cannot survive with deficient blood supply and glucose concentrations. Moreover, a number of case reports have shown that spontaneous remission of syndromes, such as acromegaly, may be caused by pituitary adenoma after apoplexy. Therefore, understanding mechanism that underlies the balance between pituitary adenoma apoplexy and subsequent spontaneous remission of syndromes may suggest new approaches for treatment of pituitary adenoma apoplexy.
垂体腺瘤卒中是一种由胰岛素输注、心脏手术、创伤及下丘脑释放因子引起的著名临床综合征。垂体卒中可导致继发性脑梗死和颈内动脉闭塞。随着肿瘤灌注的阻断,卒中会引发突然发作的头痛、视力障碍、颅神经麻痹、意识障碍、眼睑下垂和偏瘫。然而,代谢需求高的垂体腺瘤细胞在血液供应和葡萄糖浓度不足的情况下无法存活。此外,一些病例报告显示,垂体腺瘤卒中后可能会导致肢端肥大症等综合征的自发缓解。因此,了解垂体腺瘤卒中与随后综合征自发缓解之间平衡的机制,可能会为垂体腺瘤卒中的治疗提供新方法。